Literature DB >> 25403920

A three-step assay for ceramide synthase activity using a fluorescent substrate and HPLC.

Timothy A Couttas1, Xin Y Lim, Anthony S Don.   

Abstract

Ceramides are a family of signalling lipids with diverse physiological functions that include pro-differentiative and pro-apoptotic signalling. Ceramides and their derivatives are major constituents of myelin, maintaining neuronal conductivity. Ceramides are synthesized by ceramide synthases, of which there are six isoforms in mammals (CERS1-6). These enzymes catalyse the transfer of a variable length fatty acid to a sphingoid base, typically sphingosine or dihydrosphingosine. We previously reported a fluorescent thin-layer chromatography assay for ceramide synthase activity. In this paper we describe an improved fluorescent assay, using HPLC to achieve clear resolution of closely related ceramide species and to facilitate easy quantification of both product and substrate. Our HPLC assay protocol eliminates the need for a chloroform extraction step. Instead a simple three-step procedure is used: (1) reactions are run; (2) reactions are terminated with addition of methanol and centrifuged; (3) products are quantified with HPLC. HPLC resolution enables assays in which multiple fatty acid substrates are used in the same reaction. Using this approach, we show that CERS2 demonstrates a preference for the monounsaturated C24:1 fatty acid substrate compared to the saturated C24:0 substrate, potentially explaining why myelin is enriched in ceramides containing the monounsaturated form of very long chain fatty acids.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25403920     DOI: 10.1007/s11745-014-3969-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  30 in total

1.  Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains.

Authors:  Leila Hejazi; Jason W H Wong; Danni Cheng; Nicholas Proschogo; Diako Ebrahimi; Brett Garner; Anthony S Don
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

Review 2.  Ceramide synthases as potential targets for therapeutic intervention in human diseases.

Authors:  Joo-Won Park; Woo-Jae Park; Anthony H Futerman
Journal:  Biochim Biophys Acta       Date:  2013-09-08

3.  A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.

Authors:  Yael Pewzner-Jung; Hyejung Park; Elad L Laviad; Liana C Silva; Sujoy Lahiri; Johnny Stiban; Racheli Erez-Roman; Britta Brügger; Timo Sachsenheimer; Felix Wieland; Manuel Prieto; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

4.  Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism.

Authors:  Thomas D Mullen; Stefka Spassieva; Russell W Jenkins; Kazuyuki Kitatani; Jacek Bielawski; Yusuf A Hannun; Lina M Obeid
Journal:  J Lipid Res       Date:  2010-10-11       Impact factor: 5.922

5.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

6.  Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes.

Authors:  Christina Ginkel; Dieter Hartmann; Katharina vom Dorp; Armin Zlomuzica; Hany Farwanah; Matthias Eckhardt; Roger Sandhoff; Joachim Degen; Mariona Rabionet; Ekrem Dere; Peter Dörmann; Konrad Sandhoff; Klaus Willecke
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

7.  Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells.

Authors:  Krishnan Venkataraman; Christian Riebeling; Jacques Bodennec; Howard Riezman; Jeremy C Allegood; M Cameron Sullards; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

8.  Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.

Authors:  Elad L Laviad; Lee Albee; Irene Pankova-Kholmyansky; Sharon Epstein; Hyejung Park; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

9.  The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver.

Authors:  K Hirschberg; J Rodger; A H Futerman
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

10.  Programmed cell death induced by ceramide.

Authors:  L M Obeid; C M Linardic; L A Karolak; Y A Hannun
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

View more
  2 in total

1.  A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism.

Authors:  Nigel Turner; Xin Ying Lim; Hamish D Toop; Brenna Osborne; Amanda E Brandon; Elysha N Taylor; Corrine E Fiveash; Hemna Govindaraju; Jonathan D Teo; Holly P McEwen; Timothy A Couttas; Stephen M Butler; Abhirup Das; Greg M Kowalski; Clinton R Bruce; Kyle L Hoehn; Thomas Fath; Carsten Schmitz-Peiffer; Gregory J Cooney; Magdalene K Montgomery; Jonathan C Morris; Anthony S Don
Journal:  Nat Commun       Date:  2018-08-21       Impact factor: 14.919

2.  Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry.

Authors:  Dominik Wigger; Erich Gulbins; Burkhard Kleuser; Fabian Schumacher
Journal:  Front Cell Dev Biol       Date:  2019-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.